Autodesk, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of Autodesk, Inc. (“Autodesk” or the “Company”) (NASDAQ: ADSK) securities between June 1, 2023 and April 16, 2024 (the “Class Period”). Click Here to Join Investigation…. Read MoreJoin Investigation
Compass Minerals International, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of Compass Minerals International, Inc. (“Compass Minerals” or the “Company”) (NYSE: CMP) securities between November 29, 2023 and March 22, 2024 (the “Class Period”). Click Here to Join Investigation…. Read MoreJoin Investigation
Lincoln National Corporation Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of Lincoln National Corporation (“Lincoln National” or the “Company”) (NYSE: LNC) securities between November 4, 2020 and November 2, 2022 (the “Class Period”). Click Here to Join Investigation…. Read MoreJoin Investigation
AST SpaceMobile, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of AST SpaceMobile, Inc. (“SpaceMobile” or the “Company”) (NASDAQ: ASTS) securities between November 14, 2023 and April 1, 2024 (the “Class Period”). Click Here to Join Investigation…. Read MoreJoin Investigation
Sharecare, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of Sharecare, Inc. (“Sharecare” or the “Company”) (NASDAQ: SHCR) securities between May 10, 2023 and March 28, 2024 (the “Class Period”). Click Here to Join Investigation…. Read MoreJoin Investigation
GoodRx Holdings, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of GoodRx Holdings, Inc. (“GoodRx” or the “Company”) (NASDAQ: GDRX) common stock between September 23, 2020 and November 8, 2022 (the “Class Period”). Click Here to Join Investigation…. Read MoreJoin Investigation
Evolv Technologies, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of Ocugen, Inc.(“Ocugen” or the “Company”) (NASDAQ: OCGN) securities between May 8, 2020 and April 1, 2024 (the “Class Period”). Click Here to Join Investigation…. Read MoreJoin Investigation
Ocugen, Inc. Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) reminds investors that a complaint has been filed on behalf of purchasers or acquirers of Ocugen, Inc.(“Ocugen” or the “Company”) (NASDAQ: OCGN) securities between May 8, 2020 and April 1, 2024 (the “Class Period”). Click Here to Join Investigation…. Read MoreJoin Investigation